Abbott Laboratories (XBUL:ABL) Accumulated other comprehensive income (loss) : лв-12,687 Mil (As of Mar. 2025)

View and export this data going back to 2022. Start your Free Trial

What is Abbott Laboratories Accumulated other comprehensive income (loss)?

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings. Abbott Laboratories's Accumulated other comprehensive income (loss) for the quarter that ended in Mar. 2025 was лв-12,687 Mil.

Abbott Laboratories's quarterly Accumulated other comprehensive income (loss) declined from Sep. 2024 (лв-13,349 Mil) to Dec. 2024 (лв-13,523 Mil) but then increased from Dec. 2024 (лв-13,523 Mil) to Mar. 2025 (лв-12,687 Mil).

Abbott Laboratories's annual Accumulated other comprehensive income (loss) increased from Dec. 2022 (лв-13,771 Mil) to Dec. 2023 (лв-13,408 Mil) but then declined from Dec. 2023 (лв-13,408 Mil) to Dec. 2024 (лв-13,523 Mil).

Abbott Laboratories Accumulated other comprehensive income (loss) Historical Data

The historical data trend for Abbott Laboratories's Accumulated other comprehensive income (loss) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Abbott Laboratories Accumulated other comprehensive income (loss) Chart

Abbott Laboratories Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Accumulated other comprehensive income (loss)

Get a 7-Day Free Trial

-15,301.95

-14,323.55

-13,771.07

-13,408.45

-13,523.05

Abbott Laboratories Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Accumulated other comprehensive income (loss)	Get a 7-Day Free Trial															-13,967.77	-13,914.75	-13,348.58	-13,523.05	-12,686.62

Abbott Laboratories Accumulated other comprehensive income (loss) Calculation

Accumulated other comprehensive income (loss) is the aggregate amount of gains or losses that are not part of retained earnings.

Abbott Laboratories Accumulated other comprehensive income (loss) Related Terms

Thank you for viewing the detailed overview of Abbott Laboratories's Accumulated other comprehensive income (loss) provided by GuruFocus.com. Please click on the following links to see related term pages.

Abbott Laboratories Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Abbott Laboratories (XBUL:ABL) » Definitions » Accumulated other comprehensive income (loss)

Comparable Companies

Traded in Other Exchanges

ABT:USA ABT:Mexico 1ABT:Italy 0Q15:UK ABL:Germany ABL:Germany ABL:Germany ABL:Germany ABT:Canada ABTT34:Brazil ABT:Austria ABT:Argentina

Address

100 Abbott Park Road, Abbott Park, IL, USA, 60064-6400

Website

https://www.abbottinvestor.com

Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.